Propecia contains finasteride, which lowers dihydrotestosterone (DHT) around susceptible scalp follicles. It is prescribed for adult men with androgenetic alopecia, also called male pattern hair loss, to slow further loss and support regrowth with continuous treatment.
Propecia is a finasteride medicine belonging to the type II 5-alpha-reductase inhibitor class. It is intended for adult men with androgenetic alopecia, also called male pattern hair loss.
The amount taken at each intake is determined individually for each person rather than being one fixed number. The product is taken by mouth as directed by the prescriber. It may be taken with food or on an empty stomach.
Higher finasteride strengths used for prostate indications should not be substituted for the prescribed hair-loss treatment. Taking more finasteride does not produce faster regrowth and may increase exposure to adverse effects.
If a dose is missed, take the next scheduled dose when appropriate rather than doubling the amount. Taking two tablets together does not compensate for missed treatment in a useful way.
Individual instructions can differ when other medicines, liver disease, or unusual dosing circumstances are involved. A prescriber or pharmacist can provide medication-specific advice before treatment begins.
The amount taken at each intake is determined individually rather than being one fixed number. Higher finasteride strengths are used for prostate conditions and follow a different clinical purpose.
Each Propecia tablet contains:
Finasteride acts on the hormonal pathway involved in follicle miniaturization. It is prescribed for men rather than used as a routine treatment for female hair loss.
The tablet is small, but the treatment works slowly. Hair follicles respond over months, not days.
Male pattern hair loss usually appears as a receding hairline, thinning at the crown, or gradual reduction in density across the top of the scalp. Androgenetic alopecia describes the same general condition in medical language.
Other causes can produce shedding. Sudden hair loss, patchy bald areas, scalp scaling, pain, redness, or widespread shedding after illness may require assessment for a different cause before finasteride is started.
Finasteride inhibits type II 5-alpha-reductase, an enzyme that converts testosterone into dihydrotestosterone, or DHT. Lower DHT exposure can reduce the gradual shrinking of genetically sensitive hair follicles and help preserve hairs that remain responsive. The mechanism and approved use of finasteride are described in regulatory product information from Health Canada and the FDA [1].
DHT is an androgen involved in the biology of susceptible scalp follicles. In androgenetic alopecia, repeated DHT exposure can shorten the growth phase and produce progressively finer hairs.
Follicle miniaturization means that a previously thick terminal hair becomes thinner, shorter, and less visible over successive growth cycles. By reducing DHT formation, finasteride can slow this process in responsive scalp areas.
The effect is not limited to a single visible patch. Finasteride changes DHT activity elsewhere in the body as well, which explains why systemic adverse effects are possible.
Propecia is intended for men with a clinical pattern consistent with androgenetic alopecia. The treatment goal may be slowing further loss, maintaining existing hair, increasing density, or producing visible regrowth in responsive areas.
Small practical errors can make treatment appear less useful or create avoidable risk.
Common mistakes include:
Extra finasteride does not accelerate the hair cycle. It can increase exposure without improving the result.
One missed tablet is not a reason to panic. Resume the usual schedule rather than trying to create a catch-up dose.
Using Propecia for sudden patchy shedding can delay assessment of another condition. Hair loss with inflammation, scarring, or systemic symptoms needs a broader clinical review.
Failing to mention finasteride before PSA testing is another important mistake. The medicine can lower PSA and affect how the result is interpreted.
Photographs taken under different lighting can also mislead. Keep the camera distance and light source consistent, and avoid comparing freshly styled hair with unstyled hair.
Women who are pregnant or may become pregnant must not take Propecia. They should not handle crushed or broken tablets because finasteride may be absorbed through the skin.
Propecia is not indicated for children or adolescents. Men with liver disease should disclose this before treatment because finasteride is extensively processed by the liver.
Finasteride may affect semen parameters in some men. Men concerned about fertility should raise the issue before starting treatment, especially when trying to conceive.
NOT for you if your hair loss is sudden, patchy, unexplained, or linked to a contraindication identified by a clinician.
Medical assessment is useful when hair loss is:
Propecia is tolerated by many men, but finasteride can cause adverse effects. The Canadian product monograph classifies reported reactions by frequency and describes sexual, psychological, breast-related, and allergic symptoms.
Reported sexual effects include:
These reactions were uncommon in clinical trials, yet they remain clinically relevant because they can affect quality of life. Some men notice symptoms early, while others report them later.
Do not dismiss a new sexual symptom or assume it must be caused by ageing. Record when it started, whether it is persistent, and whether any other medication changed at the same time.
Persistent sexual symptoms after stopping have been reported. The appropriate response depends on the individual situation and should be discussed with the prescriber.
Mood changes, depressed mood, anxiety, and suicidal thoughts require attention. A new severe change in mood needs prompt medical review.
If suicidal thoughts, an immediate safety concern, or an inability to stay safe occurs, contact local emergency services or a crisis service immediately. Do not remain alone while waiting for help.
The EMA has highlighted the need for men taking finasteride to recognize psychological symptoms and seek medical attention when they occur [3].
Contact a clinician promptly for:
A new breast lump needs assessment rather than reassurance. Severe swelling or breathing difficulty may indicate a serious allergic reaction and requires urgent care.
Treatment choice depends on diagnosis, contraindications, treatment goals, scalp tolerance, and willingness to use a daily medicine. The options below differ in both mechanism and safety profile.
| Treatment | Main mechanism and use | Key considerations |
|---|---|---|
| Propecia, finasteride 1 mg | Lowers DHT by inhibiting type II 5-alpha-reductase; used for male pattern hair loss | Oral systemic treatment; sexual and mood adverse effects require attention; results develop over months |
| Topical minoxidil | Supports hair-follicle growth through a non-hormonal topical mechanism | Applied to the scalp; irritation and adherence can limit use; unwanted facial hair is possible |
| Oral minoxidil | Systemic vasodilator used off-label in some hair-loss plans | May affect blood pressure, heart rate, fluid balance, and body hair; requires careful medical selection |
Propecia has a hormonal mechanism, while topical minoxidil acts locally through a different pathway. Oral minoxidil has broader cardiovascular effects and should not be treated as a casual substitute.
Some clinicians use more than one approach for selected patients. Combination treatment should be planned individually because additive benefit is not guaranteed and adverse-effect monitoring becomes more important.
Clinical guidance from NICE and the American Academy of Dermatology Association supports individualized assessment when managing hair loss and related medication decisions [4].
In clinical practice, physicians usually set expectations before prescribing finasteride: the main early success may be stabilization rather than obvious new growth. A patient who keeps the same density over six to twelve months may be receiving meaningful benefit. Doctors also look for the correct pattern of loss. Diffuse shedding, patchy alopecia, scalp inflammation, or rapid onset should prompt a broader assessment instead of automatic treatment for androgenetic alopecia. A clinician would usually review sexual function, mood, breast symptoms, other medicines, liver history, fertility concerns, and the need for PSA testing. These details are part of safe prescribing, not reasons to hide symptoms.
Finasteride is not generally known for causing routine sedation, but dizziness, low mood, anxiety, sleep disturbance, or other individual reactions can occur. Health Canada’s 2024 product information supports caution when symptoms could affect alertness or concentration [5]. Avoid driving or operating machinery if you feel impaired, dizzy, unusually tired, or unable to concentrate. New severe mood symptoms require prompt medical attention rather than simply changing the time of the dose.
Propecia can be taken with or without food. The 2024 Health Canada product monograph does not require a specific meal relationship for the usual 1 mg regimen. Taking it with breakfast may make daily use easier, while taking it at another consistent time is also acceptable. Food timing does not compensate for missed tablets or make hair growth occur faster.
Seek urgent medical help for suicidal thoughts, severe depression, facial or throat swelling, breathing difficulty, or a rapidly developing allergic reaction. A new breast lump, nipple discharge, or significant breast enlargement requires prompt medical assessment. Health Canada and the EMA describe psychological, breast-related, and allergic symptoms as clinically relevant safety concerns in finasteride treatment. Sexual symptoms should be reported to the prescriber, especially when persistent, but they do not automatically require an unsupervised stop.
Women who are pregnant or may become pregnant must not take finasteride because exposure can harm a developing male fetus. The 2023 EMA safety communication reinforces the need to avoid handling crushed or broken tablets during pregnancy. Propecia is not a routine female hair-loss treatment. Breastfeeding women should not use or handle damaged tablets without specific medical direction because finasteride exposure may pose a risk to a male infant.
The first few months may bring little visible change, and a few weeks is too early to judge the result. The 2024 Health Canada information supports longer-term assessment, with a more useful review around six months and possible fuller benefit by twelve months. Some men mainly notice stabilization rather than obvious regrowth. Hair loss commonly resumes after discontinuation because the DHT-lowering effect does not continue indefinitely.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Finasteride suppresses DHT while treatment continues. If Propecia is stopped, the protective effect gradually fades and androgenetic hair loss generally resumes over time.
Stopping and restarting repeatedly makes it difficult to judge the true response. It can also create the impression that the treatment stopped working when the main issue is interrupted exposure.
The tablet coating reduces contact with the active ingredient during ordinary handling. Broken tablets require extra care, and exposure should be washed off promptly with soap and water.
Finasteride can lower blood prostate-specific antigen, or PSA, values. A lower PSA result may therefore appear reassuring even when clinical interpretation requires adjustment.
Tell every clinician ordering or interpreting a PSA test that you take finasteride. This includes testing arranged for routine prostate assessment or investigation of urinary symptoms.
Clinical evidence on finasteride for male androgenetic alopecia supports assessment over longer treatment periods rather than rapid conclusions [2].
I used Propecia 1 mg daily for several months and did not see a meaningful change at the crown. The thinning continued, so I stopped after discussing it with my prescriber.
After taking the 1 mg tablet daily, I noticed less scalp showing near the crown by about six months. The improvement was gradual, but the extra density was clear in my usual bathroom mirror.
I took Propecia 1 mg daily after watching the hairline recede for years. By the end of the first year, it looked steadier and I felt more comfortable keeping my hair short.
Taking Propecia 1 mg daily seemed to slow the shedding, but the change was smaller than I hoped. I also noticed a mild reduction in libido for a while and discussed whether to continue.
I stayed consistent and took the 1 mg tablet with my breakfast most days. Around the six-month mark, the crown looked fuller in photographs, which was the result I wanted.
